Literature DB >> 18401309

[Age-related macular degeneration and risk of stroke].

V Biousse1, M-G Bousser, A Gaudric.   

Abstract

Age-related macular degeneration (ARMD) and stroke are common causes of disability in subjects over 40 years of age. The etiology of ARMD remains unknown and numerous epidemiological studies have suggested a relationship between vascular risk factors and ARMD. A direct relationship between stroke and ARMD has also been suggested. An update on the association between ARMD and stroke is discussed in this article.

Entities:  

Mesh：

Year:  2008        PMID： 18401309      PMCID： PMC2998757          DOI： 10.1016/s0181-5512(08)70343-7

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN： 0181-5512            Impact factor:   0.818


  134 in total

1.  Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: promises and pitfalls.

Authors:  Karl Csaky
Journal:  Ophthalmology       Date:  2003-05       Impact factor: 12.079

2.  The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study.

Authors:  Ronald Klein; Barbara E K Klein; Sandra C Tomany; Karen J Cruickshanks
Journal:  Ophthalmology       Date:  2003-04       Impact factor: 12.079

3.  Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration.

Authors:  Margaret M DeAngelis; Fei Ji; Ivana K Kim; Scott Adams; Antonio Capone; Jurg Ott; Joan W Miller; Thaddeus P Dryja
Journal:  Arch Ophthalmol       Date:  2007-01

4.  Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Gabriella Tikellis; Cong Sun; Ronald Klein; David J Couper; A Richey Sharrett
Journal:  Ophthalmology       Date:  2007-01       Impact factor: 12.079

5.  Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study.

Authors:  Andrew A Moshfeghi; Philip J Rosenfeld; Carmen A Puliafito; Stephan Michels; Erin N Marcus; Joshua D Lenchus; Anna S Venkatraman
Journal:  Ophthalmology       Date:  2006-10-05       Impact factor: 12.079

6.  Is early age-related macular degeneration associated with cerebral MRI changes? The Atherosclerosis Risk in Communities study.

Authors:  Andrea Grosso; Thomas H Mosley; Ronald Klein; David J Couper; Gabriella Tikellis; Tien Y Wong
Journal:  Am J Ophthalmol       Date:  2006-08-31       Impact factor: 5.258

7.  Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.

Authors:  Jeffrey S Heier; David S Boyer; Thomas A Ciulla; Philip J Ferrone; J Michael Jumper; Ronald C Gentile; Debbi Kotlovker; Carol Y Chung; Robert Y Kim
Journal:  Arch Ophthalmol       Date:  2006-11

8.  Physical activity and the 15-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  M D Knudtson; R Klein; B E K Klein
Journal:  Br J Ophthalmol       Date:  2006-10-31       Impact factor: 4.638

9.  Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort.

Authors:  Jie Jin Wang; Suriya Foran; Wayne Smith; Paul Mitchell
Journal:  Arch Ophthalmol       Date:  2003-05

10.  Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio.

Authors:  Johanna M Seddon; Jennifer Cote; Nancy Davis; Bernard Rosner
Journal:  Arch Ophthalmol       Date:  2003-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.